CBDYX
Price
$56.27
Change
-$0.16 (-0.28%)
Updated
Aug 15 closing price
Net Assets
10.13B
CLBFX
Price
$37.32
Change
-$0.09 (-0.24%)
Updated
Aug 15 closing price
Net Assets
256.26B
Interact to see
Advertisement

CBDYX vs CLBFX

Header iconCBDYX vs CLBFX Comparison
Open Charts CBDYX vs CLBFXBanner chart's image
Columbia Balanced Inst3
Price$56.27
Change-$0.16 (-0.28%)
VolumeN/A
Net Assets10.13B
American Funds American Balanced 529F
Price$37.32
Change-$0.09 (-0.24%)
VolumeN/A
Net Assets256.26B
CBDYX vs CLBFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CBDYX vs. CLBFX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBDYX is a StrongBuy and CLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBFX has more cash in the bank: 256B vs. CBDYX (10.1B). CLBFX (1.97) and CBDYX (1.91) have matching dividends . CBDYX was incepted earlier than CLBFX: CBDYX (13 years) vs CLBFX (23 years). CLBFX (0.67) is less costly to investors than CBDYX (0.60). CBDYX is a more actively managed with annual turnover of: 200.00 vs. CLBFX (44.00). CLBFX has a lower initial minimum investment than CBDYX: CLBFX (250) vs CBDYX (1000000). CLBFX annual gain was more profitable for investors over the last year : 8.11 vs. CBDYX (6.81). CLBFX return over 5 years is better than : 40.98 vs. CBDYX (29.72).
CBDYXCLBFXCBDYX / CLBFX
Total Expense Ratio0.600.6790%
Annual Report Gross Expense Ratio0.600.6790%
Fund Existence13 years23 years-
Gain YTD9.6649.84798%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets10.1B256B4%
Annual Yield % from dividends1.911.9797%
Returns for 1 year6.818.1184%
Returns for 3 years27.5031.1588%
Returns for 5 years29.7240.9873%
Returns for 10 years68.6082.3283%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUPN42.690.52
+1.23%
Supernus Pharmaceuticals
OMC76.310.90
+1.19%
Omnicom Group
IDAI2.700.02
+0.93%
T Stamp Inc
BCYC7.440.06
+0.81%
Bicycle Therapeutics plc
RSSS2.87N/A
N/A
Research Solutions